Latest news

Filter by
Date
Mar 11, 2018 10:00 AM

Major funding boost for prostate cancer in NSW

A new $3.75 million collaborative project aims to accelerate personalised approaches to prostate cancer treatment – and is part of a total package of $12 million awarded to cancer researchers at Garvan and across NSW.

Feb 27, 2018 04:12 PM

Garvan researchers make a splash at the Lorne Genome Confere...

Garvan congratulates four scientists who received awards at the 2018 Lorne Genome Conference 2018 for their research into cancer, chemotherapy resistance, epigenetics and genomic technology.

Feb 21, 2018 08:58 AM

DreamLab users complete Project Decode

Thanks to 122,000 users, the DreamLab app has achieved an exciting milestone; Project Decode has reached 100% complete.

MEDIA RELEASE: Feb 14, 2018 12:00 PM

New app delivers practical support

CanDo is designed to make it easier to ask for and accept help when living with a serious illness.

MEDIA RELEASE: Feb 08, 2018 12:44 PM

Setting their sights on cancer relapse

An Australian-led team has been shortlisted for Cancer Research UK's Grand Challenge Award: the world's most ambitious cancer research grant.

Feb 05, 2018 01:01 PM

John Mattick: Four ways precision medicine is making a diffe...

Precision medicine is fast becoming a reality – making it possible to analyse an individual’s genetic makeup and to use that information to select the best treatments. In this article, first published in The Conversation...

Feb 02, 2018 05:30 PM

Funding needed for rare cancer treatment and research

Professor David Thomas, Head of Garvan’s Cancer Division and leader of the Australian Genomic Cancer Medicine Program, recently spoke about the state of funding for those with rare cancer.

Jan 26, 2018 06:29 AM

Australia Day Award for Garvan’s Dunia Alarkawi

Garvan researcher Dunia Alarkawi’s outstanding accomplishments have been acknowledged with an Australia Day Award from the National Council of Women of NSW.

Jan 24, 2018 01:30 PM

Researcher profile: Dr Marcia Munoz

Group Leader - Imaging and Inflammation

Jan 22, 2018 09:00 PM

Key support for Garvan’s cancer research in 2018 and beyond

Garvan researchers are thrilled to be among the recipients of grants in recently announced funding schemes from the National Breast Cancer Foundation and Cancer Australia. The funding will provide crucial support for a n...

MEDIA RELEASE: Jan 10, 2018 06:15 AM

When we exercise, our muscles and other organs communicate v...

Garvan researchers have shown, for the first time, that exercise allows the body’s tissues to communicate with each other using tiny protein-filled packages known as vesicles.

Jan 06, 2018 12:00 PM

Finding dormant cancer cells

A dormant cancer cell is like a ticking time bomb. It evades chemotherapy only to spontaneously wake and resume its deadly progress. Now, armed with pioneering tech and bold determination, researchers are finally beginni...

Dec 14, 2017 05:30 PM

Rare cancer patients in ACT gain local access to Garvan’s cl...

The Australian Genomic Cancer Medicine Program, led by Garvan’s Professor David Thomas, will be expanded to the Canberra Region Cancer Centre.

Dec 06, 2017 04:49 PM

Rogue cells and more: 19 Garvan projects attract NHMRC fundi...

A project to track down ‘rogue’ cells in the blood of people with autoimmune disease is one of 19 Garvan research projects to be funded by NHMRC in its latest funding round. Announced today, the Project Grants total $13....

Dec 04, 2017 03:07 PM

Reading DNA in real time: Garvan’s new long-read sequencing ...

Garvan has added nanopore sequencing to its toolbox of systems to analyse human genomes, opening up new possibilities for research and deeper insights into the genetics of health and disease.

Nov 29, 2017 01:39 PM

Senate report a boost for research into low survival cancers...

Garvan welcomes the Senate Select Committee report into Funding for Research into Cancers with Low Survival Rates, tabled this week in Parliament.

Nov 23, 2017 09:37 AM

Small but mighty: the tiny molecules that regulate cancer ce...

A Garvan-led research team has performed the largest ever study of how ‘microRNAs’ function in cancer cells. Hundreds of these tiny molecules play an important role in whether cancer cells live or die, the researchers fo...

Nov 16, 2017 03:13 PM

How genes drive prostate cancer: all in the packaging?

Garvan researchers have shown that a unique protein, H2A.Z, which packages DNA in cells, may drive the progression of prostate cancer. When it becomes chemically ‘tagged,’ H2A.Z uncoils and re-organises the DNA in cancer...

MEDIA RELEASE: Nov 16, 2017 06:46 AM

Pancreatic cancer: Avner Foundation awards major grants to i...

On World Pancreatic Cancer Day, the Avner Pancreatic Cancer Foundation has awarded grants of over $900,000 to Garvan's pancreatic cancer researchers. The grants will support ambitious new research into the 'matrix' surro...

Nov 14, 2017 02:52 PM

Pancreatic cancer: a lucky quirk in Ros’ DNA holds the key t...

In long-term survivors of pancreatic cancer, the immune system sees the cancer as an infectious disease – and so is empowered to attack and destroy tumour cells, according to new research from the US and Australia. This ...

Nov 10, 2017 10:31 AM

Garvan researchers shine across Australia

Garvan congratulates five early career researchers who received awards at two national meetings last week – the annual conference of Australasian Genomic Technologies Association (AGTA), and Epigenetics 2017.